Julie Andrews is of RxSight, Inc.. Currently has a direct ownership of 30,287 shares of RXST, which is worth approximately $1.53 Million. The most recent transaction as insider was on Jun 14, 2024, when has been sold 15,625 shares (Common Stock) at a price of $58.18 per share, resulting in proceeds of $909,062. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.3K
0% 3M change
30.15% 12M change
Total Value Held $1.53 Million

Julie Andrews Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 14 2024
SELL
Open market or private sale
$909,062 $58.18 p/Share
15,625 Reduced 34.03%
30,287 Common Stock
Jun 06 2024
BUY
Grant, award, or other acquisition
-
2,554 Added 5.27%
45,912 Common Stock
Jun 01 2023
BUY
Grant, award, or other acquisition
-
5,731 Added 11.67%
43,358 Common Stock
Jun 02 2022
BUY
Grant, award, or other acquisition
-
8,624 Added 18.65%
37,627 Common Stock
Aug 03 2021
BUY
Open market or private purchase
$250,000 $16.0 p/Share
15,625 Added 35.01%
29,003 Common Stock
Aug 03 2021
BUY
Grant, award, or other acquisition
-
13,378 Added 50.0%
13,378 Common Stock

Also insider at

OFIX
Orthofix Medical Inc. Healthcare
JA

Julie Andrews

Aliso Viejo, CA

Track Institutional and Insider Activities on RXST

Follow RxSight, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXST shares.

Notify only if

Insider Trading

Get notified when an Rx Sight, Inc. insider buys or sells RXST shares.

Notify only if

News

Receive news related to RxSight, Inc.

Track Activities on RXST